There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Facilitating Innovation to Fight Coronavirus Act

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to provide certain limitations on liability for actions taken by health care providers to combat COVID-19.

Actions Overview (1)

Date Actions Overview
05/06/2020Introduced in Senate

All Actions (1)

Date All Actions
05/06/2020Read twice and referred to the Committee on the Judiciary.
Action By: Senate

Cosponsors (0)

No cosponsors.

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Judiciary05/06/2020 Referred to

As of 08/03/2020 no related bill information has been received for S.3630 - Facilitating Innovation to Fight Coronavirus Act

Latest Summary (1)

There is one summary for S.3630. View summaries

Shown Here:
Introduced in Senate (05/06/2020)

Facilitating Innovation to Fight Coronavirus Act

This bill provides immunity from civil liability to health care providers for certain actions taken during the COVID-19 (i.e., coronavirus disease 2019) public health emergency and lengthens the terms of certain medical patents related to the treatment of COVID-19.

Specifically, when testing for or treating COVID-19 during the public health emergency, a health care provider may not be held liable in any federal, state, or local civil proceeding for (1) using or modifying a medical device for an unapproved use or indication; (2) practicing without a license or outside of an area of specialty, if instructed to do so by an individual with such a license or within such an area of speciality; or (3) conducting the testing of, or providing treatment to, a patient outside of the premises of standard health care facilities.

Additionally, certain medical patents that are issued with respect to the treatment of COVID-19 are deemed not to begin until the termination of the presidential emergency declaration relating to COVID-19 and are extended for an additional 10 years.